USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TRANSGENOMIC, INC.
Address:
12325 Emmet Street
Omaha, NE 68164-4268
Phone:
(240) 631-2001
URL:
N/A
EIN:
191178935
DUNS:
969419258
Number of Employees:
116
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $99,353.00 1
STTR Phase I $400,000.00 3

Award List:

The Molecular Culture

Award Year / Program / Phase:
2004 / STTR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Research Institution:
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): In the clinical setting, molecular microbiologic detection methods have classically focused on a single microorganism or a small group of microorganisms. Broad range molecular detection of bacteria in clinical specimens is an approach that parallels a… More

SBIR Phase I: Surveyor Endonuclease Adaptor-Ligated Libraries for Genomic Mutation Analysis

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$99,353.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project develops a novel process allowing rapid and cost-effective analysis of genetic variation between test and known, control genomes. The method, known as SEAL, will allow researchers to construct DNA libraries containing only these… More

Early Detection of Pancreatic Cancer Using Ice COLD-PCR

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Grant Wu – 402-452-5416
Research Institution:
UNIVERSITY OF NEBRASKA MEDICAL CENTER
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Ninety percent of all pancreatic cancers are pancreatic ductal adenocarcinoma (PDAC). PDAC diagnosis is difficult, usually occurring in the late stages of disease. Patients with these advanced tumors typically respondpoorly to therapy. Post diagnosis, median… More

Temperature-Tolerant COLD-PCR enables mutation-enriched targeted re-sequencing

Award Year / Program / Phase:
2013 / STTR / Phase I
Award Amount:
$200,000.00
Agency:
HHS
Principal Investigator:
Katherine A. Richardson – 402-452-5416
Research Institution:
DANA-FARBER CANCER INSTITUTE
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Cancers develop from the life-long accumulation of critical somatic mutations due to DNA-damaging agents that lead to cells transforming into tumor-forming cells. These low-level tumor-associated somatic DNA mutations can have profound implications for… More